ACADIA Pharmaceuticals
ACAD
#3905
Rank
NZ$4.07 B
Marketcap
$24.58
Share price
-1.11%
Change (1 day)
-31.35%
Change (1 year)

EPS for ACADIA Pharmaceuticals (ACAD)

EPS in 2023 (TTM): -$1.49

According to ACADIA Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$1.49. In 2022 the company made an earnings per share (EPS) of -$2.17 a decrease over its 2021 EPS that were of -$1.70.

EPS history for ACADIA Pharmaceuticals from 2003 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.49-31.14%
2022-$2.1727.62%
2021-$1.70-41.67%
2020-$2.9112.5%
2019-$2.59-17.95%
2018-$3.15-17.02%
2017-$3.800.43%
2016-$3.7843.56%
2015-$2.6373.4%
2014-$1.52113.64%
2013-$0.7118.92%
2012-$0.60-15.91%
2011-$0.71-210%
2010$0.65-133.61%
2009-$1.92-30.81%
2008-$2.787.5%
2007-$2.59-0.62%
2006-$2.604.55%
2005-$2.49-14.61%
2004-$2.92-84.26%
2003-$18.52

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$0.44-129.35%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.01-302.17%๐Ÿ‡บ๐Ÿ‡ธ USA
$8.78-690.14%๐Ÿ‡บ๐Ÿ‡ธ USA
$22.77-1,631.01%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.42-531.52%๐Ÿ‡บ๐Ÿ‡ธ USA